Yisimei Technology develops body cavity tumor treatment equipment and formulates clinical treatment plans.
Yisimei Technology develops hyperthermic infusion tumor therapy (HIPEC) equipment and consumables, and provides overall medical solutions for the prevention of cancer implantation and metastasis before, during, and after surgery for patients with advanced body cavity tumors.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2021 | Series A | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BIOCHING CAPITAL | — | Series A |